Otonomo Technologies Ltd. (Otonomo), (NASDAQ:OTMO), provider of a pioneering platform and marketplace for vehicle data and positioned at the epicenter of the data revolution in the automotive and mobility space,
Gainers
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints.
Following the market opening Monday, the Dow traded down 0.01% to 34,326.18 while the NASDAQ fell 1.4% to 14,362.69. The S&P also fell, dropping 0.51% to 4,334.77.
Upgrades
For Bouygues (OTC:BOUYF), Jefferies upgraded the previous rating of Hold to Buy. At the moment, the stock has a 52-week-high of $43.06 and a 52-week-low of $33.96. Bouygues closed at $42.20 at the end of the last trading period.